Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
The Journal of Investigative Dermatology|July 10, 2001
Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formationF Bachmann, S A Buechner, M Wernli, et al.American Journal of Hematology|June 26, 2001
Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLLM Heizmann, P Itin, M Wernli, et al.Praxis|January 31, 2002
[Cervical tuberculous lymphadenopathy--a rare complication of myelodysplastic syndrome]S Stoll, P Itin, T Bregenzer, et al.Cancer Genetics and Cytogenetics|August 25, 1999
Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemiaM J Bargetzi, D Mühlematter, A Tichelli, et al.Gene Therapy|January 22, 2005
Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNAJ Ji, M Wernli, A Mielgo, et al.Schweizerische Medizinische Wochenschrift|February 2, 1991
[Immunoglobulin deficiency after repeated plasmapheresis]C Stebler, A Tichelli, H Dazzi, et al.Journal of Clinical Microbiology|June 10, 1998
High human herpesvirus 8 seroprevalence in the homosexual population in SwitzerlandN Regamey, G Cathomas, M Schwager, et al.The Journal of Clinical Investigation|February 12, 1998
Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicideS A Buechner, M Wernli, T Harr, et al.Journal of Clinical Microbiology|March 1, 1996
Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodiesP Burgisser, F Simon, M Wernli, et al.BJU International|February 27, 2004
Features and preliminary results of prostate cancer screening in Canton Aargau, SwitzerlandM Kwiatkowski, A Huber, B Stamm, et al.Pageof 6